Libra Infusions Statistics

Total Valuation

Libra Infusions has a market cap or net worth of BDT 1.90 billion.

Market Cap	1.90B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Libra Infusions has 2.25 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	2.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 1,196.59.

PE Ratio	1,196.59
Forward PE	n/a
PS Ratio	9.62
PB Ratio	0.99
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 0.48.

Current Ratio	0.65
Quick Ratio	0.22
Debt / Equity	0.48
Debt / EBITDA	31.80
Debt / FCF	-174.68
Interest Coverage	0.97

Financial Efficiency

Return on equity (ROE) is 0.08% and return on invested capital (ROIC) is 0.49%.

Return on Equity (ROE)	0.08%
Return on Assets (ROA)	0.36%
Return on Capital (ROIC)	0.49%
Revenue Per Employee	281,876
Profits Per Employee	2,266
Employee Count	699
Asset Turnover	0.05
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.76%
50-Day Moving Average	870.65
200-Day Moving Average	804.25
Relative Strength Index (RSI)	41.20
Average Volume (20 Days)	15,085

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Libra Infusions had revenue of BDT 197.03 million and earned 1.58 million in profits. Earnings per share was 0.70.

Revenue	197.03M
Gross Profit	77.89M
Operating Income	22.22M
Pretax Income	2.26M
Net Income	1.58M
EBITDA	28.79M
EBIT	22.22M
Earnings Per Share (EPS)	0.70

Full Income Statement

Balance Sheet

The company has 14.39 million in cash and 915.38 million in debt, giving a net cash position of -901.00 million or -399.93 per share.

Cash & Cash Equivalents	14.39M
Total Debt	915.38M
Net Cash	-901.00M
Net Cash Per Share	-399.93
Equity (Book Value)	1.91B
Book Value Per Share	845.97
Working Capital	-104.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.67 million and capital expenditures -19.91 million, giving a free cash flow of -5.24 million.

Operating Cash Flow	14.67M
Capital Expenditures	-19.91M
Free Cash Flow	-5.24M
FCF Per Share	-2.33

Full Cash Flow Statement

Margins

Gross margin is 39.53%, with operating and profit margins of 11.28% and 0.80%.

Gross Margin	39.53%
Operating Margin	11.28%
Pretax Margin	1.15%
Profit Margin	0.80%
EBITDA Margin	14.61%
EBIT Margin	11.28%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.12%.

Dividend Per Share	1.00
Dividend Yield	0.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	0.58%
Buyback Yield	n/a
Shareholder Yield	0.12%
Earnings Yield	0.08%
FCF Yield	-0.28%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Libra Infusions has an Altman Z-Score of 0.79. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	n/a